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The SEARCH for Diabetes in Youth Study prospectively
identified youth aged <20 years with physician-diagnosed
diabetes. Annual type 1 diabetes (T1D) incidence per
100,000 person-years (95% CI) overall, by age-group,
and by sex were calculated for at-risk non-Hispanic white
(NHW) youth from 2002 through 2009. Joinpoint and
Poisson regression models were used to test for temporal
trends. The age- and sex-adjusted incidence of T1D in-
creased from 24.4/100,000 (95% CI 23.9–24.8) in 2002 to
27.4/100,000 (26.9–27.9) in 2009 (P for trend = 0.0008). The
relative annual increase in T1D incidence was 2.72%
(1.18–4.28) per year; 2.84% (1.12–4.58) per year for males
and 2.57% (0.68–4.51) per year for females. After adjust-
ment for sex, significant increases were found for youth
aged 5–9 years (P = 0.0023), 10–14 years (P = 0.0008),
and 15–19 years (P = 0.004) but not among 0–4-year-olds
(P = 0.1862). Mean age at diagnosis did not change. The
SEARCH study demonstrated a significant increase in
the incidence of T1D among NHW youth from 2002
through 2009 overall and in all but the youngest age-
group. Continued surveillance of T1D in U.S. youth to
identify future trends in T1D incidence and to plan for
health care delivery is warranted.
Type 1 diabetes (T1D) remains the predominant form of
diabetes in childhood (1,2). An increase in incidence over
the past three decades worldwide, with significant geo-
graphic variation, has been reported (3–11), with some
studies showing a downward shift in the age at diagnosis
(6–8,12). Although several U.S. registries have demon-
strated increases in T1D incidence over the past four
decades (13–16), these studies individually represent lim-
ited geographic areas. The objectives of the current study
were to examine the trends in T1D incidence among non-
Hispanic white (NHW) youth from 2002 through 2009
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and to determine whether the age at diagnosis changed
over the study period.
RESEARCH DESIGN AND METHODS
Study Design and Data Collection
Since 2002, SEARCH for Diabetes in Youth has been
a multicenter epidemiologic study conducting population-
based case ascertainment of youth diagnosed with di-
abetes before age 20 years. Youth were identified from
centers in California (health plan enrollees from one plan
in 7 counties), Colorado (64 counties), Ohio (8 counties),
South Carolina (46 counties), and Washington State (5
counties). All centers included endocrinologists in their
surveillance networks, with additional cases identified
through other health care providers, hospitals, community
health centers, clinical and administrative data systems, and
diabetes registries. Case reports were validated according to
physician diagnosis. Eligibility based on age, county or area
of residence, nonmilitary and noninstitutionalized status,
and health plan membership at diagnosis (California only)
was confirmed, and cases were registered centrally. The
ascertainment window was 30 months after 31 December
of each incident year. The study was approved by the
institutional review board at each center, with case ascer-
tainment and registration performed under a waiver of
written informed consent.
All registered youth were invited to complete a survey
that included questions about their race/ethnicity. For
incident years 2002–2006 and 2008, all youth with non-
secondary diabetes were invited to a research visit. Writ-
ten informed consent and assent, when appropriate, were
obtained (2,17). Blood samples collected during this visit
were analyzed for two diabetes autoantibodies (DAAs),
GAD65 antibody and IA-2 antibodies, by standardized
protocol (18).
Statistical Analysis
Based on the 2002–2003 T1D incidence rate among NHW
youth from SEARCH (2), power calculations assuming
a significance level of 5% demonstrated 90% power to
detect a relative 2% change [consistent with observations
in other parts of the world (9)] and a 0.48 absolute change
in incidence rate through 2009. The annual numerators
included all NHW incident T1D patients (types 1, 1a, and
1b) who were ,20 years old on 31 December of the index
year. Race/ethnicity was based on self-report (83.5%),
medical records (12.7%), or imputation (3.8%). The an-
nual denominators included NHW youth ,20 years old on
31 December of the index year who were civilian noninsti-
tutionalized residents of the geographic study areas or
members of Kaiser Permanente Southern California (2).
The annual T1D incidence was expressed per 100,000
youth by using data pooled across the five centers.
Ninety-five percent CIs were calculated using the skew-
corrected inverted score test assuming a binomial distri-
bution (19). Rates were calculated for all youth by four age
categories and by sex, with final estimates presented
overall, adjusted by age and sex (independently and com-
bined) and by sex, adjusted by age. We presented rates for
youth ,15 years old for comparison with European stud-
ies. Age- and sex-adjusted rates were calculated using di-
rect adjustment with the 2002–2009 U.S. intercensal
population estimates. Trends in incidence were tested
with Poisson regression models that included age cate-
gory, sex, and diagnosis year as covariates and then re-
peated in age-specific models to determine statistically
significant trends in incidence within each of the four
age categories. Joinpoint Regression Program version
4.04 (http://surveillance.cancer.gov/joinpoint) was used
to determine specific inflection points in trends or
whether trends were linear.
Completeness of case ascertainment for the four geo-
graphically based centers was assessed by using the
capture-recapture method (20) and a two-mode ascertain-
ment model (inpatient vs. outpatient sources) (2). Approx-
imately 2% were inpatient only, 33% from outpatient only,
and 65% from both sources. The membership-based center
did not have the independent data sources required for this
method.
The mean age at T1D diagnosis was calculated overall
and by sex for each year. We fit a general linear regression
model and examined whether significant differences
existed in age at diagnosis across the 8-year study period.
To identify potential changes in the diagnosis of T1D that
could affect trends, we compared the prevalence of the
two DAAs among youth with a research visit for 3 incident
years from the beginning (2002), middle (2005), and
nearest to the end (2008) by using general linear models
(continuous variables) and the x2 and Cochran-Armitage
tests for trend (categorical variables).
RESULTS
From 2002 through 2009, 5,842 NHW youth with T1D
were ascertained from a population of 22,927,337 person-
years. Ascertainment completeness overall and by sex was
very high, averaging 98.9% (95% CI 98.6–99.1) across the
8-year study period and exceeding 99% for all age-groups
except 15–19-year-olds (95.3% [95% CI 95.0–95.6]). The
incidence of T1D in NHW youth increased from an age-
and sex-adjusted rate of 24.4/100,000 (95% CI 23.9–24.8)
in 2002 to 27.4/100,000 (95% CI 26.9–27.9) in 2009
(Table 1). Poisson regression models demonstrated a sig-
nificant linear increase in incidence (P = 0.0008). The
relative annual increase in incidence was estimated to
be 2.72% (95% CI 1.18–4.28) per year. Joinpoint analysis
showed no evidence of inflection points (data not shown).
After adjustment for sex in age-group–stratified models,
we found significant linear increases in incidence among
youth ages 5–9 years (P = 0.002), 10–14 years (P, 0.001),
and 15–19 years (P = 0.004) but not among 0–4-year-olds
(P = 0.19) (Fig. 1A).
The incidence increased from 25.9/100,000 in 2002 to
28.2/100,000 in 2009 in males (Fig. 1B) and from 22.8 to
26.7/100,000 in females (Fig. 1C), with mean annual
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Figure 1—Incidence of T1D among NHW youth aged <20 years at diagnosis overall and by sex and age category: the SEARCH for
Diabetes in Youth Study, 2002–2009. A: Total sample. B: Males. C: Females. ■, all youth; ○, 0–4-year-olds; □, 5–9-year-olds; ▲, 10–14-
year-olds; ●, 15–19-year-olds.
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increases of 2.84% (95% CI 1.12–4.58) and 2.57% (0.68–
4.51), respectively. Among males, there was a significant
linear increase in incidence in 5–9-year-olds (P = 0.006)
and 10–14-year-olds (P = 0.02) but not among 0–4-year-olds
(P = 0.75) or 15–19-year-olds (P = 0.08). Among females,
there was a significant linear increase in 5–9-year-olds (P =
0.001) and 10–14-year-olds (P = 0.004), a decrease among
0–4-year-olds (P = 0.03), and no change among 15–19-year-
olds (P = 0.43).
The incidence of T1D in NHW youth ,15 years of age
increased from an age- and a sex-adjusted rate of 28.0/
100,000 in 2002 to 32.2/100,000 in 2009 (Table 2). The
estimated relative annual increase for youth ,15 years of
age was 2.72% (95% CI 1.09–4.36) to 2.68% (0.51–4.88)
for females and 2.75% (0.76–4.78) for males.
The mean 6 SD age at diagnosis ranged from 9.44 6
4.62 years in 2003 to 9.99 6 4.33 years in 2007 (Table 1)
and did not differ significantly across the study period for
the total sample (P for trend = 0.08) or by sex. However,
the mean age at diagnosis for all years combined was
lower for females (9.46 6 4.36 years) than for males
(10.12 6 4.62 years, P , 0.001). There was no significant
difference in the proportion of youth who were DAA pos-
itive for incident years 2002, 2005, and 2008 overall or by
age-group (Table 3).
DISCUSSION
The SEARCH study, the largest and most contemporary
registry of incident diabetes in North America, observed
a significant increasing trend in T1D incidence among
NHW youth from 2002 through 2009. On average, T1D
incidence increased by 2.72% annually. Incidence in-
creased in all age-groups except 0–4 years. Age at diagno-
sis did not change significantly. DAA positivity remained
consistent, suggesting that using a physician’s diagnosis
of T1D as the case definition resulted in similar cases over
time.
Compared with SEARCH incidence rates, the Philadel-
phia Pediatric Diabetes Registry did not find an increase
in T1D incidence for NHW youth ,15 years old from
1985 to 2004 (P = 0.69) (14). This registry’s 5-year ad-
justed T1D incidence for 2000–2004 based on 99 cases
was 19.2/100,000, which is much lower than the SEARCH
rates of 27.4–28.1/100,000 youth ,15 years of age in
2002–2004 based on 1,779 cases. Similarly, the Chicago
Childhood Diabetes Registry found no linear trend in T1D
incidence among NHW youth,18 years of age from 1994
to 2003 (13). It reported T1D incidence rates for 1999–
2003 of 15.9 and 14.7/100,000 for males and females,
respectively, based on 94 cases, which are also much lower
than the SEARCH incidence rates for males and females
,19 years of age (23.2 and 23.9/100,000, respectively) in
2003. The lack of significant trends in T1D rates in the
Philadelphia and Chicago registries (13,14) may have been
a result of their limited power to detect changes in trends.
Combining data from two registries, Colorado reported an
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NHW youth ,20 years of age from 1978 to 1988 and
2002 to 2004 (15,16), an estimate identical to the current
study’s estimate of 2.72%. A study in Newfoundland and
Labrador (Canada) reported that T1D incidence in youth
,15 years of age rose from 29.9/100,000 in 1987 to
49.9/100,000 in 2010 based on 931 cases, with increases
observed across three age-groups (21).
The median annual change in T1D incidence for youth
,15 years of age from the 23 EURODIAB centers was
3.3% per year from 1999 to 2008 (9). Finland observed
an annual increase of 3.6% from 1988 until 2005, peaking
at 64.9/100,000 in 2006 followed by a plateau through 2011
(22,23). Similarly, Sweden reported significant increases
from 1978 to 1984 and then a plateau from 2005 to
2007 (43.9/100,000) (7), with similar rates reported from
2007 to 2011 based on drug registry data (24). In compar-
ison, SEARCH observed a slightly smaller increase (2.7% per
year) but continued to see a rise after 2005 when the North-
ern European centers noted a plateau. The SEARCH 2009
T1D incidence rate for NHW youth ,15 years of age of
32.1/100,000 is well below that observed in these Scandina-
vian countries.
Although the Swedish registry reported a downward
shift in age at diagnosis from 1978 to 2000 and a reversal
from 2000 to 2007 (7), a recent reanalysis of several
sources of data from Sweden suggested that the previ-
ously published rates of T1D during adolescence and
young adulthood (ages 15–34 years) may have been sig-
nificantly underestimated, calling into question the mag-
nitude of the shift to younger ages at onset (24). Because
these revised analyses did not include cumulative inci-
dence rates for ages 0–34 years, it is not possible to
determine whether overall cumulative T1D incidence rates
changed or remained stable, as previously suggested (12).
The SEARCH study did not observe a downward shift in
the age at diagnosis, and the duration of the SEARCH
study was not long enough to assess potential shifts in
age of onset by birth cohort as was done in Sweden.
The data suggest that the peak age of T1D onset may be
younger in females than in males. Data from the Finnish
cohort suggested a similar sex difference in age of onset
(22), whereas a recent review of 31 studies on T1D inci-
dence found no sex differences in the 0–14-year age-group
(25). Overall, differences between the results of SEARCH
and other large population-based studies may be due to
differences in genetic and environmental risk factors asso-
ciated with the risk for T1D or for age of onset.
Although the present capture-recapture estimates
suggest that case ascertainment completeness is lower
for 15–19-year-olds, potentially underestimating rates by
up to 5%, this would not affect the estimates of trends
and average annual increases because they were observed
across the study period. We observed a 2.5% decline in
the denominator over the period, which was relatively
consistent across the surveillance areas. Future reports
will include additional years of incidence data and assess
trends for other racial/ethnic groups. This study also has
multiple strengths. The size and geographic variation of
the populations under surveillance by SEARCH are much
larger than all other U.S.-based childhood diabetes regis-
tries. Analyses of the distribution of income and educa-
tion among adults in the regions comprising the SEARCH
study suggest that SEARCH is representative of the U.S.
population (www.searchfordiabetes.org/public/dspPubs.cfm)
Table 3—Presence of selected DAAs among SEARCH participants with physician-diagnosed T1D from the 2002, 2005, and 2008
incident cohorts who completed a SEARCH baseline study visit and had DAAs measured: the SEARCH for Diabetes in Youth
Study
Incidence Year
2002 2005 2008 P value* P value for trend†
n 316 324 469 — —
Age at visit (years) 11.1 (4.0) 11.1 (4.0) 10.5 (44) 0.05 0.02
T1D duration (months) 13.0 (7.0) 7.8 (5.2) 8.2 (5.5) ,0.0001 ,0.0001
DAA+ status
GAD65+ 186 (58.9) 184 (56.8) 288 (61.4) 0.42 0.53
IA-2A+ 224 (70.9) 230 (71.0) 351 (74.8) 0.36 0.25
Either DAA+ 267 (84.5) 278 (85.8) 413 (88.1) 0.34 0.16
DAA+ by age category (years)‡
0–4 years 20/22 (90.9) 21/28 (75.0) 52/61 (85.2) 0.29 0.62
5–9 years 89/102 (87.3) 85/98 (86.7) 134/152 (88.2) 0.94 0.85
10–14 years 108/131 (82.4) 122/141 (86.5) 152/174 (87.4) 0.45 0.21
$15 years 50/61 (82.0) 50/57 (87.7) 75/82 (91.5) 0.24 0.09
DAA+ by sex‡
Female 121/139 (87.1) 128/145 (88.3) 183/204 (89.7) 0.75 0.46
Male 146/177 (82.5) 150/179 (83.8) 230/265 (86.8) 0.43 0.23
Data are mean (SD) or n (%) unless otherwise indicated. IA-2A, IA-2 antibodies. *P values for continuous variables were fit by using
a general linear model with time period treated as a class variable. P values for categorical variables are based on x2 test. †P values for
continuous variables were fit using a general linear model with time period treated as a continuous variable. P values for categorical
variables were tested using the Cochran-Armitage test for trend. ‡Data are number positive/total tested (%).
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(1). Methodological strengths include multiple approaches to
case ascertainment, a uniform case definition of diabetes
applied across the study period, a high case ascertainment
rate, and phenotypic information demonstrating the consis-
tent case definition over time. SEARCH previously reported
a good concordance between physician-diagnosed and etio-
logic diabetes type (26).
In conclusion, SEARCH demonstrated that T1D in-
cidence has been increasing among NHW youth in the
U.S. Particularly given the recent plateauing of T1D
incidence in Europe, continuing childhood diabetes sur-
veillance in the U.S. is essential to identify future trends
and potential causes of these increases.
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